by Vora Corporate Finance | Feb 24, 2024 | Insights, Merger & Acquisitions
M&A: Sony terminates merger deal with Zee Entertainment Transaction: Sony pictures entertainment gave a statement confirming sending termination notice to Zee Entertainment Enterprise Ltd., ending proposed $10 billion merger in India. Sony served the termination...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Secondary Market: The BSE Sensex closed at71,752.11 by -0.68% and the Nifty 50 closed at 21,725.70 by -0.03% in the month of January 2024. There’s a noticeable rally in cyclical stocks, driven by the broader economic outlook and expectations of growth. The increased...
by Vora Corporate Finance | Feb 24, 2024 | Insights, Private Equity & IPO
PE: PlasmaGen Biosciences Raises $27 Million in Series C round. Transaction: Plasmagen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, has raised INR 225 crores, led by UK based Artian...
by Vora Corporate Finance | Feb 24, 2024 | Insights, Merger & Acquisitions
M&A: Max Healthcare acquires Sahara Hospital, Lucknow at an Enterprise Value of Rs 940 Crores. Transaction: Max Health said it was acquiring a 100% stake in 550 Bedded Sahara Hospital at an enterprise value of Rs 940 Crore, representing an enterprise value/sales...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Secondary Market: The Indian stock markets continued their rally with substantial gains at Nifty 50 and Sensex gaining 7.94% at 21,731.40 and 7.84% at 72,240.26 respectively. The Nifty Index finished the year with a gain of 20.03%, experiencing a remarkable surge of...
